Sleep Apnea Treatment Cuts Nighttime Heartburn, Respiratory Symptoms
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 5, 2023 -- Treatment with positive airway pressure (PAP) for obstructive sleep apnea (OSA) for two years is associated with a decrease in nighttime heartburn and respiratory symptoms, according to a study published online Aug. 30 in ERJ Open Research.
Össur Ingi Emilsson, M.D., from University of Iceland in Reykjavik, and colleagues studied the effect of PAP treatment on nocturnal gastroesophageal reflux (nGER) and respiratory symptoms among 732 patients with newly diagnosed OSA.
The researchers found that PAP treatment among full users resulted in a decreased presence of nGER (adjusted odds ratio [aOR], 0.58) and wheezing (aOR, 0.56) at two-year follow-up compared with partial/non-PAP users. Across levels of PAP use, decreases in nGER were associated with a decrease in productive morning cough (aOR, 4.70) and a decrease in chronic bronchitis (aOR, 3.86). However, decreases in nGER were not associated with decreased wheezing (aOR, 0.90; 95 percent confidence interval, 0.39 to 2.08). PAP treatment directly led to a decrease in wheezing, which was not mediated through nGER. However, decreased productive cough with PAP treatment was mediated through a decrease in nGER.
“For OSA patients with wheezing or nGER, PAP treatment is likely to have a beneficial effect,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Improved GERD Questionnaire Scores Seen With Antireflux Mucosectomy
WEDNESDAY, July 3, 2024 -- For patients with refractory gastroesophageal reflux disease (GERD), those receiving antireflux mucosectomy (ARMS) have a greater improvement in the...
Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation
TUESDAY, July 2, 2024 -- Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2...
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.